P

Proterris, Inc

6 employees

Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2005

Funding rounds raised

P

Proterris, Inc raised undisclosed on December 31, 2017

Investors: Portugal Ventures

FAQ